NO20013856L - Krystallinsk form av eplerenon med okt opplosningshastighet - Google Patents

Krystallinsk form av eplerenon med okt opplosningshastighet

Info

Publication number
NO20013856L
NO20013856L NO20013856A NO20013856A NO20013856L NO 20013856 L NO20013856 L NO 20013856L NO 20013856 A NO20013856 A NO 20013856A NO 20013856 A NO20013856 A NO 20013856A NO 20013856 L NO20013856 L NO 20013856L
Authority
NO
Norway
Prior art keywords
eplerenone
octal
crystalline form
dissolution rate
dissolution
Prior art date
Application number
NO20013856A
Other languages
English (en)
Norwegian (no)
Other versions
NO20013856D0 (no
Inventor
Kathleen P Barton
Thomas Borchardt
Marlon V Carlos
Subhash Desai
Leonard J Ferro
Henry T Gaud
Scott Ganser
Clay R Little
Partha S Mudipalli
Mark A Pietz
Daniel R Pilipauskas
Yuen-Lung L Sing
Glenn L Stahl
Joseph J Wieczorek
Chris Y Yan
Original Assignee
Pharmacia Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia Corp filed Critical Pharmacia Corp
Publication of NO20013856D0 publication Critical patent/NO20013856D0/no
Publication of NO20013856L publication Critical patent/NO20013856L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0005—Oxygen-containing hetero ring
    • C07J71/001—Oxiranes
    • C07J71/0015—Oxiranes at position 9(11)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A61K31/585—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin containing lactone rings, e.g. oxandrolone, bufalin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Neurology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Psychiatry (AREA)
  • Biomedical Technology (AREA)
  • Hospice & Palliative Care (AREA)
  • Neurosurgery (AREA)
  • Urology & Nephrology (AREA)
  • Pain & Pain Management (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
NO20013856A 1999-12-08 2001-08-08 Krystallinsk form av eplerenon med okt opplosningshastighet NO20013856L (no)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US16963999P 1999-12-08 1999-12-08
US16968299P 1999-12-08 1999-12-08
US16960899P 1999-12-08 1999-12-08
US16955699P 1999-12-08 1999-12-08
US16969099P 1999-12-08 1999-12-08
US16980799P 1999-12-08 1999-12-08
PCT/US2000/032416 WO2001042272A2 (en) 1999-12-08 2000-12-04 Eplerenone crystalline form exhibiting enhanced dissolution rate

Publications (2)

Publication Number Publication Date
NO20013856D0 NO20013856D0 (no) 2001-08-08
NO20013856L true NO20013856L (no) 2001-10-08

Family

ID=27558585

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20013856A NO20013856L (no) 1999-12-08 2001-08-08 Krystallinsk form av eplerenon med okt opplosningshastighet

Country Status (17)

Country Link
EP (1) EP1177204A2 (enExample)
JP (1) JP2003516414A (enExample)
KR (1) KR100607923B1 (enExample)
CN (2) CN1152886C (enExample)
AU (1) AU784946B2 (enExample)
BR (1) BR0008057A (enExample)
CA (1) CA2362669A1 (enExample)
CO (1) CO5280211A1 (enExample)
EA (1) EA007934B1 (enExample)
HU (1) HUP0203032A3 (enExample)
IL (3) IL144764A0 (enExample)
MX (1) MXPA01008056A (enExample)
MY (1) MY131878A (enExample)
NO (1) NO20013856L (enExample)
NZ (2) NZ530028A (enExample)
PE (1) PE20010917A1 (enExample)
WO (1) WO2001042272A2 (enExample)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1487540A2 (en) * 2002-03-20 2004-12-22 Pharmacia Corporation Storage stable eplerenone formulation
US7235655B2 (en) 2002-03-22 2007-06-26 Pharmacia & Upjohn Company Processes to prepare eplerenone
CA2582496A1 (en) 2007-03-20 2008-09-20 Apotex Pharmachem Inc. Improved process for the preparation and purification of eplerenone
EP2568986B1 (en) 2010-05-10 2016-01-13 INSERM (Institut National de la Santé et de la Recherche Médicale) Methods and compositions for the treatment of fluid accumulation in and/ or under the retina
EP2582365B1 (en) 2010-06-16 2019-03-20 INSERM (Institut National de la Santé et de la Recherche Médicale) Compositions for stimulating reepithelialisation during wound healing
US20180280414A1 (en) 2015-10-13 2018-10-04 Inserm (Institut National De La Sante Et De La Recherche Medicale) Methods and pharmaceutical compositions for the treatment of choroidal neovascularisation
GB201609607D0 (en) 2016-06-01 2016-07-13 Kalvista Pharmaceuticals Ltd Polymorphs of N-(3-Fluoro-4-methoxypyridin-2-yl)methyl)-3-(methoxymethyl)-1-({4-((2-oxopy ridin-1-yl)methyl)phenyl}methyl)pyrazole-4-carboxamide and salts
EP3490606B8 (en) 2016-07-26 2024-04-10 INSERM (Institut National de la Santé et de la Recherche Médicale) Antagonist of mineralocorticoid receptor for the treatment of osteoarthritis
GB201719881D0 (en) 2017-11-29 2018-01-10 Kalvista Pharmaceuticals Ltd Solid forms of plasma kallikrein inhibitor and salts thereof
CN108059648A (zh) * 2017-12-30 2018-05-22 合肥久诺医药科技有限公司 一种依普利酮溶剂合物及其制备方法
WO2023031277A1 (en) 2021-08-31 2023-03-09 INSERM (Institut National de la Santé et de la Recherche Médicale) Methods for the treatment of ocular rosacea
WO2023204729A1 (ru) * 2022-04-19 2023-10-26 Общество с ограниченной ответственностью "Гелеспон" Фармацевтические композиции на основе новой субстанции 4-[2-(1н-имидазол-4-ил)-этилкарбамоил]-бутановой кислоты и способ получения субстанции
CN120754115A (zh) * 2025-05-23 2025-10-10 远大医药（中国）有限公司 一种含依普利酮组合物及其药物制剂、制备方法和用途

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4559332A (en) * 1983-04-13 1985-12-17 Ciba Geigy Corporation 20-Spiroxanes and analogues having an open ring E, processes for their manufacture, and pharmaceutical preparations thereof
NZ336004A (en) * 1996-12-11 2001-04-27 G Process for preparation of 3-keto-7-alpha-alkoxycarbonyl substituted delta-4,5-steroid by reacting 4,5-dihydro-5,7-lactone steroid substrate in the presence of a base
JP2002538172A (ja) * 1999-03-05 2002-11-12 ジー．ディー．サール エルエルシー 循環器疾患治療のためのアンギオテンシン変換酵素阻害薬およびエポキシ−ステロイドアルドステロン拮抗薬の組合せ療法

Also Published As

Publication number Publication date
HUP0203032A3 (en) 2003-04-28
BR0008057A (pt) 2002-04-23
CN1377365A (zh) 2002-10-30
WO2001042272A9 (en) 2002-12-12
CA2362669A1 (en) 2001-06-14
WO2001042272A2 (en) 2001-06-14
IL144764A (en) 2007-08-19
MXPA01008056A (es) 2003-07-21
HUP0203032A2 (hu) 2002-12-28
NO20013856D0 (no) 2001-08-08
KR100607923B1 (ko) 2006-08-04
EA007934B1 (ru) 2007-02-27
KR20010112261A (ko) 2001-12-20
HK1050536A1 (en) 2003-06-27
PE20010917A1 (es) 2001-09-10
NZ513961A (en) 2004-02-27
NZ530028A (en) 2005-08-26
WO2001042272A3 (en) 2001-11-29
IL144764A0 (en) 2002-06-30
AU784946B2 (en) 2006-08-03
CN1152886C (zh) 2004-06-09
EA200100871A1 (ru) 2002-04-25
CN1557833A (zh) 2004-12-29
CO5280211A1 (es) 2003-05-30
JP2003516414A (ja) 2003-05-13
EP1177204A2 (en) 2002-02-06
MY131878A (en) 2007-09-28
AU2049201A (en) 2001-06-18
IL176511A (en) 2007-08-19

Similar Documents

Publication Publication Date Title
IS5989A (is) Nýtt kristallað form kalíumsalts (S)-ómeprasóls
NO20005467D0 (no) Krystalloscillator med styrt impulstid
DE60017540D1 (de) Mehr-herzbereiche reizungssystem mit bedingter refraktärer periode
EE200300001A (et) Perindopriili tert-butüülamiinsoola kristallilinealfa-vorm
PL352296A1 (en) Crystalline derivatives of 1-methylocarbapeneme
NO20023072D0 (no) Syntese av krystallinske silikoaluminofosfater
NO20013856D0 (no) Eplerenonkrystallinsk form med okt opplosningshastighet
IL147244A0 (en) Process for preparing substituted cyclopentane derivatives and novel crystalline structures thereof
NO20013857D0 (no) Krystallinsk form av Eplerenon
ATE339438T1 (de) Substanziell kristalline form von melagatran
NO20014301L (no) Sammensetninger med kontrollert frigivelse av betahistin
DK1026465T3 (da) Anlæg til termisk behandling af melformede råmaterialer
NO20022956D0 (no) Fremgangsmåte for fremstilling av nitroguanidin
HUP0203382A3 (en) Process for the preparation of ketimines
ITMI991737A0 (it) Composizioni a rilascio controllato di paracetamolo
NO20020328D0 (no) Fremgangsmåte for fremstilling av 4-cyano-2-aminometyltiazol
ZA200107145B (en) Eplerenone crystalline form exhibiting enhanced dissolution rate.
NO20020327D0 (no) Fremgangsmåte for fremstilling av 2-aminometyl-4-cyano-tiazol
FI974176A0 (fi) Polypropen med hoeg kristallisationsgrad
DE60038936D1 (de) Einkristallziehvorrichtung
TW381472U (en) Improvement of the attamperater for cold/hot plastering
SE9904417D0 (sv) Crystalline form
DK1272500T3 (da) Fremgangsmåde til fremstilling af 6-O-alkenylsubstituerede erythromycinderivater
NO995364D0 (no) Rör med festeanordning for sammenbinding av betongvegger
TW380715U (en) Improvement of the wedging structure for alarm clock

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application